Combination HIV antibody infusions safely maintain viral suppression in select individuals
Friday, September 28, 2018 - 09:00
in Health & Medicine
A small group of people living with HIV sensitive to two potent anti-HIV broadly neutralizing antibodies(link is external) (bNAbs) — 3BNC117 and 10-1074 — tolerated multiple infusions of the antibodies and suppressed HIV for more than 15 weeks after stopping antiretroviral therapy (ART). The new findings, from a pilot clinical trial supported by the National Institutes of […]